Experts call for both standardized diagnosis and innovative treatment for asthma
In the interview, Zhang Min further emphasized the importance of standardized diagnosis and treatment. She stated that the diagnosis rate of asthma is less than 30%, and some primary hospitals still have missed or misdiagnosed cases due to equipment limitations. The new guidelines recommend using methods such as lung function testing and exhaled nitric oxide (FeNO) to improve diagnostic accuracy, and if necessary, diagnostic treatment can be used.
Regarding the selection of inhalation therapy devices, Zhang Min explained that dry powder inhalers (DPI) do not require hand mouth coordination and are suitable for most patients; Pressure quantitative inhaler (pMDI) should pay attention to hand mouth synchronization; Soft fog inhaler (SMI) is suitable for patients with low inspiratory flow rate. Patients should choose the most suitable device under the guidance of a professional doctor and regularly evaluate the usage method, "she added.
For pediatric patients, she specifically reminds parents that their concerns about ICS may stem from misunderstandings about hormone side effects. Research has shown that standardized use of low-dose ICS not only does not affect children's growth and development, but also reduces the use of systemic hormones during acute attacks. For example, ICS combined with long-acting β 2 receptor agonists (such as formoterol) has a significant effect on reducing acute asthma attacks in children.
By combining standardized treatment, innovative therapies, and public education, we hope to enable more asthma patients to achieve 'clinical cure' and regain free breathing, "said Zhang Min.

